CURANEX PHARMACEUTICALS INC (CURX)
Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline
Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline
NUBURU Provides Corporate Update Highlighting Initial Revenue Traction and ~$6M+ Combined Pipeline Across Software and Directed-Energy Verticals
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas
American Ocean Minerals Corporation to Merge with Odyssey Marine Exploration, Inc., Creating a $1B U.S.-Controlled Deep-Sea Critical Minerals Platform
Rocket Lab Completes at the Market Offering
PMGC Holdings Inc. [NASDAQ: ELAB] Fully Utilizes All Available in $20M Equity Financing Facility, Strengthens Cash Position and Advances Multi-Sector Acquisition Strategy
Exodus Movement, Inc. March 2026 Treasury Update and Monthly Metrics
UTHR: United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP® for Treatment of Acute Liver Failure
FiscalNote Expands PolicyNote API with District Matching Capability to Power Organizations’ Grassroots Advocacy Efforts
Oscar Mayer Unveils First Bacon Innovation in Five Years with New Maple Bourbon Bacon